Home » Topics » Regulatory » Patents

Patents
RSS

Dainippon reports anti-H. pylori compounds

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Byk Gulden claims agents for H. pylori control

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

5alpha-Reductase inhibitors for BPH disclosed by Lilly

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Antirestenosis agents reported by Fujisawa, Teijin

April 26, 1996

ACE/NEP inhibitors claimed by Fujisawa

April 26, 1996

New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...